Everyone Had Something Right: A Historiographical Reassessment of THCA-A/CB1 Receptor Pharmacology

Abstract

The claim that phytocannabinoids other than THC are pharmacologically inert at CB1 and CB2 rests on a body of receptor-binding literature that is usually described, when it is discussed at all, as "contradictory." This piece traces that literature — beginning with the isolation of the first cannabinoid ever characterized in 1896, through a sixty-nine-year gap before the acidic cannabinoids were even correctly identified, into a modern gas-chromatography artifact that inflated cannabinol quantification for decades, and finally into the specific in vitro binding-affinity studies of tetrahydrocannabinolic acid A (THCA-A) at CB1 — and finds that nearly every point of apparent disagreement traces to an identifiable defect at the level of measurement, material purity, or citation, rather than to a genuine biological inconsistency. A six-category taxonomy is proposed to classify these defects and to distinguish primary-science dissonance (terminological drift, measurement error, settled knowledge misread as controversy) from citation-layer dissonance introduced downstream of the primary science (unreconstructable data, citation fabrication, and compound-class substitution). The central case study — a THCA-A/CB1 affinity value attributed to Verhoeckx et al. (2006) and cited by at least two subsequent reviews with mutually inconsistent numbers — is reconstructed in full chronological detail and shown to derive from an assay that was outsourced, never published with data or method, and confirmed by the original corresponding author, eleven years later, as unreconstructable even in her own memory. The piece does not argue that acidic cannabinoids are CB1/CB2 ligands. It argues that the literature currently cited to say they are not has not been checked closely enough to support that conclusion, and it proposes a citation and assay-reporting standard intended to prevent the same failure mode from recurring. Read individually, nearly every contested citation in this reconstruction turns out to be a defensible report of what its own author actually measured; the instability comes from how the record was assembled and re-cited afterward, not from the scientists who did the original work disagreeing with each other. KEYWORDS Cannabinoid receptor pharmacology; THCA-A; CB1; CB2; receptor-binding assays; citation verification; historiography of science; analytical chemistry; scientific literature integrity; measurement artifacts